Merck Millipore, the life science division of Merck, has promoted Andrew Bulpin to head of the company's Process Solutions Business Unit. He is currently head of Global Pharmaceutical Chemicals Solutions Sales at the US firm.
Bulpin takes up his new role on 14 May and will be based at the company's US headquarters in Massachusetts. He succeeds Jean-Paul Mangeolle, who is retiring from the company after 28 years of service.
Bulpin joined Millipore Corporation in 2006 as vp for the Upstream Processing Business Unit and, in January this year, assumed leadership of the Services and Solutions Business. Following the company's acquisition by Merck, he was appointed to his current position.
Prior to Merck Millipore, Bulpin worked at Serologicals Corporation in a number of sales and marketing roles both in the US and Europe.
